Moderna (MRNA) Stock Has More Fuel Left in the Tank, Says Analyst

With the public desperate for a solution to COVID-19, Moderna’s (MRNA) status has increased to such an extent that any good news coming out of its HQ ripples across the whole market. Moderna can take partial credit for the S&P 500’s uptick on Wednesday, following news of the positive development in its COVID-19 vaccine program.A study published in the New England Journal of Medicine showed that in the Phase 1 study of the biotech’s experimental vaccine mRNA-1273, all 45 patients produced antibodies to the coronavirus.Moreover, participants who received two 100-microgram doses of the vaccine (patients were given either 250, 100, …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.